glp-1 obesity drug market news today Asia Pacific Agonists Weight Loss Drugs Size & Outlook, 2030 Glp-1 Analogues Market Size, Share

Persistent whole day meal effects of three dipeptidyl peptidase-4 inhibitors on glycaemia and hormonal responses in metformin-treated type 2 diabetes

doi: 10.1002/jnr.24781 71 LimJWLeeJPaeAN

Only 13 states provided coverage as of January 2026, down from 16 states in 2025, likely reflecting the significant costs of coverage and recent state budget challenges and federal funding cuts

GLP-1 RA ever users were defined as patients who used GLP-1 RAs within 3 months prior to transplant but discontinued their use afterward

Because they help reproduce or enhance the effects of a naturally occurring gut hormone that assists in the control of blood sugar levels, they can also reduce appetite by working on brain hunger centers

E.EganJ